Q: Where are you located?
A: Sepracor's corporate headquarters are located at 84 Waterford Drive in Marlborough, Massachusetts, which is approximately 45 minutes west of downtown Boston.
Q: What kinds of drugs do you develop?
A: Sepracor's drug development program and collaboration partnership arrangements have yielded a portfolio of pharmaceutical products and candidates with a focus on the treatment of respiratory and central nervous system disorders. More information about our pharmaceuticals in development can be found in the Products and Pipeline section of this web site.
Q: I am a patient and I have a question about your product. Who should I call?
A: Please call our Customer Assistance Center at 1-888-394-7377.
Q: I am a physician and I have a question about your product. Who should I call?
A: Please call our Medical Information Department at 1-800-739-0565.
Q: Where can I find information on participating in a clinical trial?
A: Please call our Customer Assistance Center at 1-888-394-7377.
Q: I am a shareholder or I am thinking about investing. How can I obtain more information about the company? A: You may contact our Investor Relations and Corporate Communications Department at 508-481-6700, or visit the For Investors section of this web site.
Q: How can I obtain a copy of your annual report?
A: Annual reports can be accessed through the For Investors section of this web site. Additional investor information such as quarterly webcasts and fact sheets can also be found there. If you would like to receive copies through the mail, please contact the Investor Relations and Corporate Communications Department at 508-481-6700.
Q: Who is my local sales representative, or how can I get in touch with a sales representative?
A: Please contact the Customer Assistance Center at 1-888-394-7377.
Q: I am a physician and would like to receive samples of your products. Who should I contact?
A: Please contact the Customer Assistance Center at 1-888-394-7377.
Q: What are your currently marketed products?
A: Sepracor's currently marketed products are XOPENEX® (levalbuterol HCl) Inhalation Solution; XOPENEX HFA® (levalbuterol tartrate) Inhalation Aerosol, a hydrofluoroalkane (HFA) metered-dose inhaler (MDI); LUNESTA® (eszopiclone); BROVANA® (arformoterol tartrate) Inhalation Solution; OMNARIS® (ciclesonide) Nasal Spray; and ALVESCO® (ciclesonide) HFA Inhalation Solution.
Q: Are any of your marketed products available internationally?
A: No, our marketed products are currently only available in the U.S.
Q: Can I get free samples of your marketed products without going to my doctor?
A: Our marketed products are available by prescription only. Your doctor, however, may have samples for you.
Q: Are your marketed products covered under the Medicare drug benefit plan?
A: XOPENEX Inhalation Solution and BROVANA are covered under Medicare Part B. OMNARIS, LUNESTA, XOPENEX HFA and ALVESCO are covered under Medicare Part D.
Q: I am interested in working for Sepracor. Where do I send my resume?
A: Please visit the Careers section of this web site for information about available positions and contact information.
Q: Can I buy or sell stock directly through Sepracor?
A: Sepracor does not offer a Direct Stock Purchase Program. Sepracor stock purchases or sales would need to be conducted by your brokerage firm.
Q: What is Sepracor's ticker symbol?
A: SEPR
Q: Who is Sepracor's Transfer Agent and Registrar?
A:
Computershare Trust Company, N.A.
PO Box 43010
Providence, RI 02940-3010
Phone: (781) 575-2879
Q: Has Sepracor ever had any stock splits?
A: Yes. On February 25, 2000, stockholders received an additional share for every share they owned as of the close of business on the record date of February 1, 2000.
Q: How can I obtain SEC documents, such as a proxy statement, 10-K or 10-Q?
A: You may obtain SEC documents by contacting the Investor Relations and Corporate Communications Department at 508-357-7740 or you may access them online through the For Investors section of this web site.
Q: How do I eliminate duplicate proxy mailings?
A: If you are a registered shareholder, contact our transfer agent and request to have your accounts consolidated.
If you are a beneficial holder, or shares are held in street name, contact your banker or broker and request to have your accounts consolidated.
Q: What is the difference between a registered shareholder and a beneficial holder (shares held in street name)?
A: A registered shareholder receives an actual stock certificate (denoting number of shares) registered in their name and controls the certificate's physical location. A beneficial holder (or street name shareholder) is a shareholder who deposits their shares in a brokerage account which holds the shares in "street name", meaning that their shares are registered in the broker's (street) name.
Q: Who do I contact with questions about my stock certificates?
A: Inquiries concerning the transfer or exchange of Sepracor shares, lost stock certificates, duplicate mailings or change of address should be directed to our Transfer Agent or Registrar:
Computershare Trust Company, N.A.
PO Box 43010
Providence, RI 02940-3010
Phone: (781) 575-2879
Q: Who should I contact if I'm a member of the media?
A: If you are a member of the media, please contact the Investor Relations and Corporate Communications Department at (508) 481-6700.